How do you incorporate trastuzumab, pembrolizumab, and FOLFOX, as per KEYNOTE-811?
2 Answers
Mednet Member
Medical Oncology · University of Vermont
I have been thinking about this a lot recently, as the original study was based on treatment with 5FU/cisplatin or capecitabine/oxaliplatin, both of which were q3 week trials. It begs the question as to whether one should consider 5FU/cis over FOLFOX in HER2-positive patients with GEJ adenocarcinoma...